Sodium Bicarbonate
Basic Information
| Item | Value |
|---|---|
| DrugBank ID | DB01390 |
| Evidence Level | L5 (Computational Prediction) |
| Number of Predicted Indications | 20 |
Predicted Indications (TxGNN)
The following are potential new indications predicted by the TxGNN model. Higher scores indicate higher predicted relevance.
| # | Indication | Source |
|---|---|---|
| 1 | bronchitis | KG + DL |
| 2 | irritable bowel syndrome | KG + DL |
| 3 | open-angle glaucoma | KG + DL |
| 4 | hyperthyroidism | KG + DL |
| 5 | resistance to thyroid hormone due to a mutation in thyroid hormone receptor beta | KG + DL |
| 6 | primary hereditary glaucoma | KG + DL |
| 7 | anaphylaxis | KG + DL |
| 8 | hyperthyroxinemia | KG + DL |
| 9 | food-dependent exercise-induced anaphylaxis | KG + DL |
| 10 | esotropia | KG + DL |
| 11 | nasal cavity disease | KG + DL |
| 12 | non-syndromic esophageal malformation | KG + DL |
| 13 | herpes simplex virus keratitis | KG + DL |
| 14 | panuveitis (disease) | KG + DL |
| 15 | pharyngitis | KG + DL |
| 16 | cauda equina syndrome | KG + DL |
| 17 | acute laryngopharyngitis | KG + DL |
| 18 | closed-angle glaucoma | KG + DL |
| 19 | esophageal disease | KG + DL |
| 20 | dermatitis | KG + DL |
Disclaimer
These predictions are for research purposes only and do not constitute medical advice. Clinical validation is required before any clinical application.